icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections (CROI)
Boston, Massachusetts
March 4-7, 2018
Back grey_arrow_rt.gif
 
 
 
Vaginal Contraceptive Hormone Exposure
Profoundly Altered by EFV- And ATV/r-based ART
AIDS Clinical Trials Group A5316
 
 
  Reported by Jules Levin
CROI 2018 March 4-7 Boston MA
 
Kimberly K. Scarsi, Yoninah S. Cramer, David Gingrich, Susan L. Rosenkranz, Francesca Aweeka, Robert Coombs, Carmen D. Zorrilla, Kristine Coughlin, Laura E. Moran, Baiba Berzins, Catherine Godfrey, Susan E. Cohn, for the AIDS Clinical Trials Group A5316 Study Team
 
WEBCAST: http://www.croiwebcasts.org/console/player/37313?mediaType=slideVideo&&crd_fl=1&ssmsrq=1522786151637&ctms=5000&csmsrq=925

0410181

0410182

0410183

0410184

0410185

0410186

0410187

0410188

0410189